statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

MIAMI, April 03, 2024 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 69th Emerging Growth Conference on April 3 & 4, 2024. The...

Presenting on the Emerging Growth Conference 69 Day 2 on April 4 Register Now

MIAMI, April 02, 2024 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 69th Emerging Growth Conference on April 3 & 4, 2024...

Presenting on the Emerging Growth Conference 69 Day 1 on April 3 Register Now

CervoMed: H2 2024 Data For DLB Program A Major Inflection Point...

CervoMed: H2 2024 Data For DLB Program A Major Inflection Point

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

CervoMed reports FY23 EPS (82c)  vs ($11.20) last year

- Announced private placement of up to $149.4 million led by RA Capital Management with participation from Armistice Capital, Special Situations Funds and Soleus Capital; pro forma cash and cash...

CervoMed Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Updates

Cervomed Inc. (CRVO) has disclosed a new risk, in the Economy & Political Environment category. Cervomed Inc. faces considerable business risk due...

Cervomed Inc. Braces for Impact: How Political Uncertainty and the Presidential Election Could Shake Up the Pharma Industry

Funding from new investors, including RA Capital Management, Armistice Capital, Special Situations Funds and Soleus Capital $50 million financing upfront with up to an additional $99.4 million tied...

CervoMed Announces Up to $149.4 Million Private Placement Financing Joined by Leading Healthcare Investors

BOSTON, March 28, 2024 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for age-related neurologic disorders, today announced that...

CervoMed to Participate in Upcoming Investor Conferences

This is a Bearish indicator signaling CRVO's price could decline from here. Traders may explore shorting the stock or put options...

CervoMed (CRVO, $19.73) Moving Average Convergence Divergence (MACD) Histogram turned negative on March 27, 2024

This is a signal that CRVO's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...

CervoMed (CRVO, $22.48) RSI Indicator left the overbought zone on March 21, 2024

CervoMed, Inc. is a clinical stage biotechnology company. It engages in the business of advancing CNS focused therapeutics to benefit patients with a range of degenerative diseases of the brain. The company is currently developing neflamapimod, an investigational orally administered small molecule brain penetrant that inhibits p38MAP kinase alpha. The company was founded in 2001 and is headquartered in Boston, MA.

Volume	31,022.00
52-Wk High	$26.38
52-Wk Low	$4.14

CRVO CervoMed Inc

About

Feed

News

Sentiment

Fundamentals